Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Joshua Abram
AddedFeb 15, 2024
UpdatedMay 31, 2026
Joshua Abram

Joshua Abram

Co-Founder, Conceivable Life Sciences

CrunchbaseLinkedInThe Org

Joshua Abram's Career

Conceivable Life Sciences
Conceivable Life Sciences

New York City, NY, US

Co-Founder
Dstillery
Dstillery

New York City, NY, US

Co-Founder
NeueHouse
NeueHouse

New York City, NY, US

Co-Founder
Tmrw Life Sciences
Tmrw Life Sciences

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Joshua Abram's Career

Conceivable Life Sciences
Conceivable Life Sciences
Seed$20M122022New York City, NY, US
Co-Founder

Leadership at Conceivable Life Sciences

Alejandro Chavez-BadiolaAlejandro Chavez-BadiolaCo-Founder

Similar to Conceivable Life Sciences

Tmrw Life SciencesTmrw Life SciencesNew York City, NY, USCell Management, IVFest. 2018Tmrw Life SciencesNew York City, NY, US · est. 2018

TMRW: A life sciences tech firm revolutionizing IVF with automated cryo-management for eggs and embryos.

Angel · $153.5M107
Overture LifeOverture LifeNew York City, NY, USFertility Treatments, IVFest. 2017Overture LifeNew York City, NY, US · est. 2017

Overture Life, a biotech firm, innovates IVF through automation and non-invasive selection, making fertility treatments affordable and reliable.

Series B · $45M42
ConceivableConceivableAustin, TX, USFertility Softwareest. 2013ConceivableAustin, TX, US · est. 2013

Conceivable, Inc.: Enhancing women's fertility naturally through innovative healthcare software in the US.

Seed · $800k8
Incept BioSystemsIncept BioSystemsAnn Arbor, MI, USInfertility Treatmentsest. 2005Incept BioSystemsAnn Arbor, MI, US · est. 2005

Enhancing IVF outcomes nationwide with innovative infertility treatments.

Series A · $3.3M3
Dstillery
Dstillery
Series D$60.4M1212008New York City, NY, US
Co-Founder

Leadership at Dstillery

David HonigDavid HonigCo-Founder
Charlie OppenheimerCharlie OppenheimerBoard Member
Tom PhillipsTom PhillipsCEO
David BellDavid BellBoard Member
Mike DiPianoMike DiPianoBoard Member
David PakmanDavid PakmanBoard Member
NeueHouse
NeueHouse
Series C$78M1792011New York City, NY, US
Co-Founder

Leadership at NeueHouse

Josh WyattJosh WyattCEO
Alan MurrayAlan MurrayCo-Founder
Gil WeisblumGil WeisblumBoard Member
Alan MurrayAlan MurrayBoard Member

Similar to NeueHouse

LaunchHouseLaunchHouseCleveland, OH, USCoaching, Communityest. 2008LaunchHouseCleveland, OH, US · est. 2008

Launch House: A curated community for top entrepreneurs, offering coliving residencies, coaching, and professional development worldwide.

Series A · $15M8
CreativelyCreativelyNew York City, NY, USCollaboration, Portfoliosest. 2019CreativelyNew York City, NY, US · est. 2019

Creatively: A global platform connecting creatives and brands through top-tier portfolios and collaborations.

Seed · $13M25
LoosecubesLoosecubesNew York City, NY, USCoworkingest. 2010LoosecubesNew York City, NY, US · est. 2010

Loosecubes: A community marketplace connecting members for shared, inspiring workspaces.

Series A · $9M6
CommonGrounds WorkplaceCommonGrounds WorkplaceCarlsbad, CA, USCoworking, Office Spaceest. 2016CommonGrounds WorkplaceCarlsbad, CA, US · est. 2016

CommonGrounds Workspace: An enterprise-grade, human-centric provider of Workplace-as-a-Service.

Series A · $140M75
Tmrw Life Sciences
Tmrw Life Sciences
Angel$153.5M1072018New York City, NY, US
Board Member· Board

Leadership at Tmrw Life Sciences

Jeffrey PortJeffrey PortCo-Founder
Tara ComonteTara ComonteBoard Member
Louis VillalbaLouis VillalbaCEO
Emily Drabant ConleyEmily Drabant ConleyBoard Member

Similar to Tmrw Life Sciences

Conceivable Life SciencesConceivable Life SciencesNew York City, NY, USFertility Treatmentsest. 2022Conceivable Life SciencesNew York City, NY, US · est. 2022

Conceivable Life Sciences: Automating IVF labs for accessible fertility treatments.

Seed · $20M12
Overture LifeOverture LifeNew York City, NY, USFertility Treatments, IVFest. 2017Overture LifeNew York City, NY, US · est. 2017

Overture Life, a biotech firm, innovates IVF through automation and non-invasive selection, making fertility treatments affordable and reliable.

Series B · $45M42
Darwin LifeDarwin LifeNew York City, NY, USIVF Technologyest. 2015Darwin LifeNew York City, NY, US · est. 2015

Darwin Life, a biotech firm, innovates in vitro fertilization tech to reverse aging effects on oocytes and prevent diseases.

Pre-Seed · $1M6
AlifeAlifeSan Francisco, CA, USAI Softwareest. 2020AlifeSan Francisco, CA, US · est. 2020

Alife Health: Pioneering AI tools for modern IVF systems, partnering with top institutions for healthier children.

Series A · $31.5M80

Joshua Abram's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Joshua Abram

Tomasz SablinskiTomasz SablinskiCo-Founder · Transparency Life SciencesJoel BraunsteinJoel BraunsteinFounder · Tivorsan PharmaceuticalsBeth SandersBeth SandersFounder · LifeBioSaqib RasoolSaqib RasoolCo-Founder · ZenLedgerMatthew KrisiloffMatthew KrisiloffCo-Founder · SciFounders